FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

23 letters match. Newest first.

  1. ZIIP, Inc.

    FDA warns ZIIP over quality-system violations and unapproved marketing of HALO 2.0, DOT, and gels.

    High risk
  2. Skytron, LLC

    Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.

    High risk
  3. Longhorn Vaccines and Diagnostics LLC

    Longhorn Vaccines and Diagnostics sold its PrimeStore MTM sample transport device without required quality controls or clearance for claims beyond its approved uses.

    High risk
  4. TG Supply LLC d/b/a TransGuy Supply

    FDA warned TransGuy Supply that its breast binders are unregistered, unlisted medical devices.

    Low
  5. Flux Lab Pte. Ltd. d/b/a The Fluxion

    FDA warns Flux Lab/The Fluxion over unregistered, unlisted chest binders marketed as medical devices.

    Medium
  6. Marli Washington Design, LLC

    Marli Washington Design (gc2b) sold breast binders as medical devices without FDA registration or listing for FY2026, making them misbranded.

    Low
  7. TomboyX, PBC

    FDA says TomboyX sells breast binders as medical devices without registering or listing them, making them misbranded.

    Medium
  8. TOMSCOUT

    FDA says TOMSCOUT sells breast binders as medical devices without required FDA registration or listing.

    Low
  9. ShapeShifter Apparel, LLC

    FDA says ShapeShifter Apparel sold breast binders as unregistered, unlisted medical devices, making them misbranded.

    Low
  10. Trans-Missie B.V.

    FDA says Trans-Missie B.V. sells breast binders as medical devices without registering or listing them with FDA.

    Low
  11. Les Encres LLC

    FDA warns Les Encres that its PDO surgical suture threads were promoted for unapproved cosmetic uses and had quality system violations.

    High risk
  12. Spectra Therapy, LLC

    FDA warns Spectra Therapy over LASERwrap infrared lamp device quality-system violations and unapproved disease-treatment claims.

    High risk
  13. Mectronic Medicale S.R.L.

    FDA warns Mectronic Medicale over quality system failures and uncleared marketing of therapeutic RF/laser devices.

    High risk
  14. Soulaire Corporation

    FDA says Soulaire marketed an ECP device for unapproved uses without clearance or approval.

    High risk
  15. Dr. Joel Kaplan Inc.

    FDA warned Dr. Joel Kaplan Inc. that its sexual health devices are unapproved, misbranded, and made under quality system violations.

    High risk
  16. Outset Medical, Inc.

    FDA warns Outset Medical over unapproved TabloCart and promotion of Tablo dialysis system for unapproved CRRT use.

    High risk
  17. RightEye, LLC

    RightEye's Vision System was marketed for unapproved uses and lacked design controls, FDA says.

    High risk
  18. Living Foods LLC

    FDA warned Living Foods LLC that its Bion+Plus, ZeoHeal and Relax Sauna were marketed with unapproved drug and device claims.

    High risk
  19. Databazaar.com

    Databazaar.com sells KN95 masks claiming COVID-19 protection without FDA approval or clearance.

    High risk
  20. Marci Beauty LLC

    Marci Beauty markets seven light therapy devices without FDA clearance or approval, with claims to treat serious diseases.

    High risk
  21. Zhejiang Xichen Medical Technology Co., Ltd.

    FDA warned Zhejiang Xichen Medical Technology for selling three face masks in the U.S. without FDA clearance and for misleading FDA registration claims.

    High risk
  22. Omega Engineering Inc.

    FDA warns Omega Engineering over unapproved TI-120GTS thermal imager sold with COVID-19 screening claims.

    High risk
  23. Omnisense Systems Pte Ltd.

    Omnisense Systems Pte Ltd offered the Sentry MK4 fever screening system for US sale without FDA approval or clearance, with COVID-19 claims.

    High risk